Xu Xu, Wang Zhao, Yang Jingang, Fan Xiaohan, Yang Yuejin
Department of Cardiology, Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
, Department of Cardiology, Coronary Heart Disease Center, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
BMC Cardiovasc Disord. 2024 Apr 23;24(1):218. doi: 10.1186/s12872-024-03889-w.
The coexistence of cardiac arrhythmias in patients with acute myocardial infarction (AMI) usually exhibits poor prognosis. However, there are few contemporary data available on the burden of cardiac arrhythmias in AMI patients and their impact on in-hospital outcomes.
The present study analyzed data from the China Acute Myocardial Infarction (CAMI) registry involving 23,825 consecutive AMI patients admitted to 108 hospitals from January 2013 to February 2018. Cardiac arrhythmias were defined as the presence of bradyarrhythmias, sustained atrial tachyarrhythmias, and sustained ventricular tachyarrhythmias that occurred during hospitalization. In-hospital outcome was defined as a composite of all-cause mortality, cardiogenic shock, re-infarction, stroke, or heart failure.
Cardiac arrhythmia was presented in 1991 (8.35%) AMI patients, including 3.4% ventricular tachyarrhythmias, 2.44% bradyarrhythmias, 1.78% atrial tachyarrhythmias, and 0.73% ≥2 kinds of arrhythmias. Patients with arrhythmias were more common with ST-segment elevation myocardial infarction (83.3% vs. 75.5%, P < 0.001), fibrinolysis (12.8% vs. 8.0%, P < 0.001), and previous heart failure (3.7% vs. 1.5%, P < 0.001). The incidences of in-hospital outcomes were 77.0%, 50.7%, 43.5%, and 41.4%, respectively, in patients with ≥ 2 kinds of arrhythmias, ventricular tachyarrhythmias, bradyarrhythmias, and atrial tachyarrhythmias, and were significantly higher in all patients with arrhythmias than those without arrhythmias (48.9% vs. 12.5%, P < 0.001). The presence of any kinds of arrhythmia was independently associated with an increased risk of hospitalization outcome (≥ 2 kinds of arrhythmias, OR 26.83, 95%CI 18.51-38.90; ventricular tachyarrhythmias, OR 8.56, 95%CI 7.34-9.98; bradyarrhythmias, OR 5.82, 95%CI 4.87-6.95; atrial tachyarrhythmias, OR4.15, 95%CI 3.38-5.10), and in-hospital mortality (≥ 2 kinds of arrhythmias, OR 24.44, 95%CI 17.03-35.07; ventricular tachyarrhythmias, OR 13.61, 95%CI 10.87-17.05; bradyarrhythmias, OR 7.85, 95%CI 6.0-10.26; atrial tachyarrhythmias, OR 4.28, 95%CI 2.98-6.16).
Cardiac arrhythmia commonly occurred in patients with AMI might be ventricular tachyarrhythmias, followed by bradyarrhythmias, atrial tachyarrhythmias, and ≥ 2 kinds of arrhythmias. The presence of any arrhythmias could impact poor hospitalization outcomes.
Clinical Trial Registration: Identifier: NCT01874691.
急性心肌梗死(AMI)患者并发心律失常通常预后较差。然而,目前关于AMI患者心律失常负担及其对住院结局影响的当代数据较少。
本研究分析了中国急性心肌梗死(CAMI)注册研究的数据,该研究纳入了2013年1月至2018年2月期间连续入住108家医院的23825例AMI患者。心律失常定义为住院期间出现的缓慢性心律失常、持续性房性快速心律失常和持续性室性快速心律失常。住院结局定义为全因死亡、心源性休克、再梗死、中风或心力衰竭的综合情况。
1991例(8.35%)AMI患者出现心律失常,其中室性快速心律失常占3.4%,缓慢性心律失常占2.44%,房性快速心律失常占1.78%,≥2种心律失常占0.73%。心律失常患者更常见于ST段抬高型心肌梗死(83.3%对75.5%,P<0.001)、接受纤溶治疗(12.8%对8.0%,P<0.001)和既往有心力衰竭(3.7%对1.5%,P<0.001)。≥2种心律失常、室性快速心律失常、缓慢性心律失常和房性快速心律失常患者的住院结局发生率分别为77.0%、50.7%、43.5%和41.4%,所有心律失常患者的住院结局发生率均显著高于无心律失常患者(48.9%对12.5%,P<0.001)。任何类型心律失常的存在均与住院结局风险增加独立相关(≥2种心律失常,OR 26.83,95%CI 18.51-38.90;室性快速心律失常,OR 8.56,95%CI 7.34-9.98;缓慢性心律失常,OR 5.82,95%CI 4.87-6.95;房性快速心律失常,OR4.15,95%CI 3.38-5.10),以及住院死亡率(≥2种心律失常,OR 24.44,95%CI 17.03-35.07;室性快速心律失常,OR 13.61,95%CI 10.87-17.05;缓慢性心律失常,OR 7.85,95%CI 6.0-10.26;房性快速心律失常,OR 4.28,95%CI 2.98-6.16)。
AMI患者中常见的心律失常可能是室性快速心律失常,其次是缓慢性心律失常、房性快速心律失常和≥2种心律失常。任何心律失常的存在都可能影响不良的住院结局。
临床试验注册:标识符:NCT01874691。